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Background: Plant Biotransformation is one of the tools for structural modifications of the organic substrate of low,
moderate or high biological value utilizing plant cultured cells, these modifications of organic structures may lead
to biologically augmented products and which may be ultimately substantial in cure or improvement of various
morbidities and diseases.
Results: Azadirachta indica A. Juss. suspension culture was employed for the biotransformation of dianabol
(1) for the first time, and two metabolites, 17β-hydroxy-17α-methyl-5α-androst-1-en-3-one (2), and 17β-hydroxy-
17α-methyl-5α-androstan-3-one (3) were obtained.
Conclusions: Most important aspect of this work was the evaluation of metabolite 2, which strongly and
differentially suppressed [not affecting whole blood and human polymorphonuclear cells (PMN)] the
phytohemagglutinin (PHA)-activated T-cell proliferation (IC50: <10.33 μM), and also found to inhibit IL-2 production
(IC50: 16.89 ± 1.32) unlike metabolite 3 and compound 1. Compound 2 also exhibited anticancer activity against
lung cancer cell line; NCI-H460, it moderately inhibited the growth of cancer cells (22.5 ± 4.15 μM). Furthermore, a
good correlation between the predicted binding energies of the compounds acquired by the FlexX program and
the experimental affinities were speculated upon interacting with IL-2 protein during molecular docking studies.
Keywords: Biotransformation, Anti-inflammatory activity, Anti-cancer activity, Molecular docking studiesBackground
Plant cell suspension cultures can serve as tools for the
in vivo production of secondary metabolites [1,2] as well
as for the biotransformation of xenobiotics [3-5]. These
cultures are considered to be useful biocatalysts for reac-
tions, such as hydroxylation at allylic positions, oxida-
tion–reduction between alcohols and ketones, and the
reduction of carbon–carbon double bonds [6,7]. Plant
cell cultures mediated biotransformations are now in-
creasingly employed by synthetic chemists for the* Correspondence: saif_sahir@yahoo.com
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This exhibits a vast biochemical potential for the pro-
duction of specific secondary metabolites. Biotransfor-
mations, using plant cells and isolated enzymes, have an
immense potential in the production of pharmaceuticals.
Plant enzyme biocatalysts may be applied to the pro-
duction of totally new drugs and also may be used to
modify existing drugs by improving their bioactivity
spectrum. The introduction of a functional group into
terpenoids and steroids is an important reaction in syn-
thetic chemistry. Many studies have been reported on
the specific oxidation, reduction of olefins, and alicyclic
hydrocarbons with chemical reagents [8-10]. The ability
of cultured plant cells to transform some organictral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Plant cell cultures and microbacteria are considered to
be useful biocatalysts for reactions such as the hydroxyl-
ation at allylic positions, the oxidation–reduction of
alcohols and ketones, and reduction of carbon–carbon
double bonds [11].
Human health is directly influenced by immune sys-
tem, and its performance, which are fundamentally
designed for the protection against the attack of foreign
invaders. However the onset of almost all infectious and
degenerative diseases is largely due to inadequate or
hyperactive immune response. Therefore, the modu-
lation of the immune system is highly demanded for
control of many immunological disorders. Therefore,
dianabol (1) was selected for this objective, potent ster-
oid, is a derivative of testosterone, exhibiting strong
anabolic and moderate androgenic properties. This com-
pound was first made available in 1960, and it quickly
became the most favoured and widely used anabolic
steroid by athletes.
In continuation of our studies [12,13], on biotrans-
formation of molecules/compounds in pursuing of more
potent and promising candidate including new drugs
for different diseases, dianabol (1) was incubated with
Azadirachta indica A Juss. cell suspension cultures,
which is employed for the first time for structural modi-
fications. A. indica has not used before for the structural
modification of organic compounds except our group
[13-15]. A. indica belongs to the family Meliaceae and is
known to human being from 2000 years. It is generally
recognized as Indian neem (margosa tree) or Indian lilac
(neem in Pakistan) and inhabited in the Asia particularly
in Pakistan and India. The neem is called ‘Arishtha’ in
sanskrit meaning ‘reliever of sickness’. Neem importance
in treating various diseases has also been distinguished
by US National Academy of Sciences as they published
a report entitled ‘Neem – a tree for solving global prob-
lems’ in 1992, this strongly suggested that neem is a
medicinal plant possessing thousands of organic com-
pounds, which in turn is important for playing pivotal
role in combating several diseases [16]. The medicinal
role of this plant evoked its biotransformational studies
in hope to have various derivatives of dianabol pos-
sessing useful therapeutic activities as a result of diversi-
fied enzymes that A. indica would have, which carry out
these structural modification.
Plant biotransformation of various steroids has already
been described by many groups in which different
reactions were observed for instances a report explains
the changes in ethynodiol diacetate by the suspension
culture of Ocimum basilicum and the same plant, in this
article biotransformation with Ocimum basilicum per-
formed hydrolysis of the ester group, oxidation of alco-
hol into ketone, and rearrangement of the hydroxylgroup and with A indica hydrolysis of the ester group,
oxidation/reduction reactions were observed [14]. Simi-
larly, biotransformation of 21-O-acetyl-deoxycorticoster-
one by cell suspension cultures of Digitalis lanata
illustrates how plant cell suspension can carry out
unique reactions; 2β-Hydroxylation and C-21-gluco-
sylation of the steroidal nucleus was being reported first
time by plant-culture cells besides 5α and 5β reduction
[17]. This the advantage of the cell suspension culture of
plants over the synthetic methods to execute different
reactions easily and cost effectively, ultimately inquiring
biologically application. Both of these plant biotrans-
formation steroid models did not mention any biological
activities unlike this study. Biotransformation of dianabol
afforded two metabolites 2 and 3 resulting from the re-
duction of olefinic double bonds, being reported for the
first time by this method. The structures of transformed
were deduced by various spectroscopic methods, are
reporting findings on the immunomodulatory role of
metabolite 2 and 3 with substrate, compound 2 is found
capable of reducing the PHA dependant Th1 response
induced in human peripheral mononuclear cells. The in-
vestigation of molecular characteristics of compounds
1–3 possibly associated with the inhibition of IL-2 pro-
tein was also carried out. A modeling study using FlexX
program was performed to dock the compounds 1–3
with the reference inhibitor 4 into the active site of the
IL-2 protein.
International patents of the metabolites 2 have re-
cently been approved and published by United States of
Patent and Trademark Office [18,19], claiming the anti-
inflammatory and anti-cancer activities.
Results
After 20 days of incubation, the cells and the media were
separated by filtration. The filtrate was extracted with
CH2Cl2 (3 × 1.5 L) and the cells were extracted in an
ultrasonic bath with CH2Cl2 (3 × 500 mL) at r. t. The
combined extract were dried over anhydrous Na2SO4,
and concentrated under reduced pressures, which aff-
orded a brown residue (1.32 g). The transformed metab-
olites were isolated from this crude by using repeated
column chromatography (silica gel) with petroleum et-
her/EtOAc gradient, afforded metabolites 2 (26 mg,
petroleum ether: EtOAc, 9.5:0.5, 5.2% yield) and 3
(18 mg, petroleum ether: EtOAc, 9.8:0.2, 3.6% yield). We
did not find any other metabolite as column was run till
the 100% of the ethyl acetate.
17β-Hydroxy-17α-methyl-5α-androst-1-en-3-one (2)
Colourless solid, m.p. 140–142°C, [α] D20 -40º (c 0.04,
CHCl3). UV (MeOH) λmax (log ε): 230 nm (3.62).
IR (CHCl3) νmax: 3445 (OH), 1674 (C =O), 1652, 1496
(C = C), 1380 cm-1 (C-O). EI-MS m/z (rel. int. %): 302
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MS m/z: 302.0122 (M+, C20H30O2; calcd 302.0120).
1H
(CDCl3, 300 MHz) and
13C NMR (CDCl3, 100 MHz).
17β-hydroxy-17α-methyl-5α-androstan-3-one (3)
Colourless solid, m.p. 152–154°C, [α]D20 -130º (c 0.02,
CHCl3). UV (MeOH) λmax (log ε): 203 nm (0.43). IR
(CHCl3) νmax: 3360 (OH), 1713 (C =O), 1372 cm
-1 (C-O).
EI-MS m/z (rel. int. %): 304 (20), 289 (28), 271 (15), 247
(45), 231 (39), 215 (14), 189 (12), 175 (16), 163 (46). HREI-
MS m/z: 304.2113 (M+, C20H32O2; calcd 304.2115).
1H
(CDCl3, 300 MHz), and
13C NMR (CDCl3, 100 MHz).
Anti-inflammatory activity
In this study, effects of metabolites 2 and 3 on the innate
immune response, in particular the reactive oxygen spe-
cies (ROS) production was examined using whole blood
phagocytes, and isolated neutrophils, which did not re-
sult in any significant effect (Table 1). In addition to
that, effects of these compounds on T-cells proliferation
were also evaluated; investigating their ability to modu-
late PHA activated T-cell proliferation response and pro-
duction of IL-2 cytokine.
Compound 2 was found to have significant inhibitory
activity on T-cell proliferation with IC50 value less than
10.33 μM compared to the initial substrate dianabol (1),
which did not show considerable effect neither on T-
cells proliferation nor IL-2 production (Figure 1). A
moderate inhibitory activity with IC50 value of 42.11 μM
was obtained with compound 3. The activity of these
two compounds was further confirmed by their effects
on IL-2 cytokine production, the main contributor in
T-cell activation. The extracellular production of IL-2
from peripheral blood mononuclear cells was signifi-
cantly inhibited (IC50 = 16.9 ± 1.32 μM) by compound 2.
On the other hand compound 3 had a moderate inhibi-
tory effect (IC50 = 49.3 ± 1.32 μM) on IL-2 production.
Anti-cancer activity
The biotransformed products and its substrate were also
screened for the anticancer activity against NCI-H460Table 1 IC50 effect of tested compounds on oxidative









1 >333.33 >166.67 >166.67 >166.67
2 >331.13 >165.56 <10.33 16.89 ± 1.32
3 >328.95 >164.47 42.11 ± 11.51 49.34 ± 1.32
Control Aa 11.2 ± 1.9 2.8 ± 0.8 - -
Control Bb - - 0.2 <0.5
aIbuprofen; bPrednisolone.cell line. During the screening, compound 2 (GI50: 22.5
± 4.15 μM and TGI: 60 ± 9.2 μM) and 1 (GI50: 28.3 ±
2.72 μM) exhibited growth inhibitory effects. The GI50
and TGI represents the concentration of compounds
exhibiting 50% and 100% (total) growth inhibition re-
spectively against the NCI-H460 cell line. The com-
pound 3 was non-active against NCI-H460 cell line as it
showed no growth inhibition (Table 2).
Docking studies
In continuation with our ongoing molecular docking stud-
ies on IL-2 [20,21], molecular docking studies were
conducted to predict the binding pattern of compounds
1–3 with IL-2. The observed binding modes suggested
that all three compounds bind at the ligand binding site of
IL-2. Prior to the docking of compounds 1–3, the per-
formance docking program was evaluated through the re-
docking experiment. For this purpose, the co-crystallized
compound 4 (reference ligand) was extracted from the X-
ray structure of protein and re-docked into the ligand
binding site using FlexX docking program. The FlexX
docking program accurately docked the reference ligand
with the RMSD value of 0.7 Å. This shows that FlexX is
suitable and can be used for the docking of comp 1–3.
The superimposed view of experimental and docked con-
formation of comp. 4 is presented in Figure 2.
Discussion
Transformation
Biotransformation of dianabol (1) by cell suspension cul-
ture of A. indica yielded compounds 2 and 3, (Scheme 1).
Compound 2 was obtained as a colourless solid. The
molecular formula C20H30O2 was deduced from the
HREI-MS at m/z 302.0122 (Calcd. 302.0120), indicating
six degrees of unsaturation. The IR spectrum showed
hydroxyl absorption at 3445, and carbonyl absorption at
1674 cm-1. The 1H NMR spectrum of compound 2
displayed only one olefinic double bond at δH 7.13, and
5.83 (each d, J1,2 = 10.2 Hz). The
13C NMR spectra also
showed disappearance of one olefinic double bond in
the compound 2. It showed additional signal of C-4
methylene (δC 41.0), and C-5 methene (δC 44.4). This
reduction also confirmed by the HMBC spectrum, in
which C-1 (δH 7.13) have J2 correlations with C-2
(δC 127.5), and C-10 (δC 39.1), and J3 correaltions with
C-3 (δC 200.1) and C-5 (δC 44.4). Similarly, C-5
(δH 1.92-1.94, m) showed J2 correlations with C-4
(δC 41.0), and C-10 (δC 39.1), and J3 correlation with C-3
(δC 200.1). The configuration of the newly introduced
proton at C-5 was assigned to be α on the basis
of NOESY correlation between H-5 with CH3-20α,
which showed a trans junction between rings A and B.





















































Figure 1 Effect of compounds on phytohemagglutinin (PHA), T-cell proliferation and IL-2 production. The bar graph represents effects of
various concentrations of the test compounds 1–3 after 72 h incubation with peripheral blood mononuclear cells at 37°C. Effect of compounds
on T-cell proliferation response is compared with non-proliferated (+ve) and proliferated (−ve) cells (a). The bar graph represent effects of various
concentrations of the test compounds (1–3) on production of IL-2 compared with (+ve) and without (−ve) PHA induced IL-2 production. Each
bar represents the mean value of triplicate reading ± SD (b).
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terone) as well as new designer steroid, and according to
a recent article, M1T is featured as a potent androgen
by using the yeast AR transactivation assay. It was fur-
ther demonstrated as potent androgen and anabolic ster-
oid both sc and peroral [23]. M1T is very similar to a
well known synthetic anabolic androgenic steroid (AAS);Table 2 Growth inhibition induced by transformed
compounds against human lung cancer cell line (NCI-H460)
Compound(s) GI50 (μM) TGI (μM)
1 28.3 ± 2.72 NDa
2 22.5 ± 4.15 60 ± 9.2
3 ND ND
Doxorubicin (control) 0.08 ± 0.02 —
aND: Values could not be determined indicates <50% inhibition of cell growth
at maximum dose (100 μM) tested.methyltestosterone (MT) [24] a 17α-methylated testos-
terone [25]. The olefinic double bond(C = C) is at C1/2
in M1T whereas in MT at C4/5 position.
Compound 3 was obtained as a white solid. The
HREI-MS of compound 3 showed the M+ at m/z
304.2113, corresponding to the formula C20H32O2
(Calcd. 304.2115). The IR spectrum showed a hydroxyl
absorption at 3360, and ketonic absorption at 1713 cm-1.
The reduction of both olefinic double bonds was in-
ferred by the absence of the all the downfield olefinic
protons in the 1H NMR spectrum of compound 3. The
13C NMR spectra of compound 3 also showed three
additional upfield methylene and a methine carbon sig-
nals i.e. C-1 (δC 38.2), C-2 (39.0), C-4 (44.7) and C-5 (δC
46.8). In the HMBC spectrum, C-19 methyl proton (δH
1.01) showed J2 correlations with C-10 (δC 35.8), and J3
correlations with C-1 (δC 38.2), and C-5 (δC 46.8). The
Figure 2 The chemical structure of compound 4. Superimposed view of docked conformation of compound 4 (RMSD 0.7 Å), shown in blue
(a) and the reference ligand shown in yellow (b).
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assigned to be α on the basis of NOESY correlation be-
tween H-5 with CH3-20α, which supported a trans junc-
tion between rings A and B [26]. Compound 3 is known
as mestanolone, a nonionizable pharmaceutical host
compounds [27] and the 17α-methylated version of di-
hydrotestosterone (DHT) [28].
The complete 1H [Additional file 1: Table S1] and 13C
NMR [Additional file 1: Table S2] assignments of
compound 2 and 3 are presented in Tables, provided as
supporting material. Both of these derivatives are well
known androgens and obtained through chemical
synthesis. Both M1T (compound 2) and Mestanolone
(compound 3) are important intermediate in the synthe-
sis of the anabolic drug oxandrolone [29].
Biological studies
Anti-inflammatory
The activity of compound 2, in contrast to the 1 and 3,
could be due to the olefinic bond between C-1/C-2.
Compound 3 did not possess a carbon-carbon double
bond, and showed lesser activity (Table 1). This sug-
gested that the activity might be due to C-1/C-2 carbon-
carbon double bond.
Anti-cancer
Compounds 1–3 have similar structures (Scheme 1) ex-
cept for one and two olefinic double bonds. Compound
2 differs by absence of one and 3 by two olefinic double
bonds. Interestingly, compound 2 has a difference of
only one olefinic double bonds at C-4 position ascompared to its parent compound; probably due to the
absence of this double bond compound 3 was not able
to inhibit considerable growth of cancer cells at 100 μM
that is why this compound was not evaluated further.
Compound 1 (substrate), which is different having two
olefinic double bond (at C-1 and C-4 positions) ex-
hibited better growth inhibition but not as discriminat-
ing as 2, which clearly suggested that absence and
presence of olefinic double bond in the given structures
is important for having the anticancer activity. Particu-
larly, double bond present at position C-1 is more
important than at C-4.
When statistical errors (Table 2) are contemplated for
compound 1 and 2 then both compounds would be con-
sidered as potent similarly, but because only compound
2 showed total growth inhibition (TGI) that is why this
could be designated as most effective compound.
Docking studies
Docking studies showed a good correlation between the
predicted binding energies of the compounds obtained
by the FlexX program and the experimental binding af-
finities. Analysis of the docking results revealed that all
three compounds bind at the same receptor site on the
surface of IL-2 protein. Comparing the binding scores of
the compounds 1–3 with the reference ligand (com-
pound 4), it was predicted that compounds 1–3 could
inhibit IL-2 protein. All three compounds showed simi-
lar binding pattern and interacts on the active site of IL-
2 protein at the surface through several active- site




































Scheme 1 Biotransformation of dianabol (1) by cell suspension cultures of Azadirachta indica, and resulting metabolites 2 and 3.
Figure 3 The docked orientations of Compound 1 (Orange), 2
(Green) and 3 (Pink) in the ligand binding site of IL-2. The
interacting amino acids are shown in Purple stick.
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two olefinic double bonds in conjugation with the car-
bonyl group of ring A at C-3. The lone pair of the car-
bonyl group is least likely to be available to interact with
surrounding amino acid residues due to conjugation.
The observed binding mode of compound 1 is shown in
Figure 4a, which shows that compound 1 is unable to
form any hydrogen bonding interaction with any sur-
rounding amino acid. This could be a reason of inac-
tivity of this compound. While in compound 2 the
carbonyl group of ring A forms bidentate interaction
with the side chain guanidinium moiety of Arg38. The
side chain Nε and NH2ŋ2 of Arg38 forms hydrogen
bonding with the carbonyl moiety at distance of 2.8 Å
and 2.2 Å, respectively (Figure 4b). The binding mode
analysis of compound 3 shows that, compound 3 also
makes weak bidentate interaction with Arg38 in com-
parison to compound 2. The observed hydrogen bond
distance between Nε and NH2ŋ2 of Arg38 and com-
pound 3 was 2.9 Å and 3.5 Å, respectively (Figure 4c).
Due to this weak interaction, compound 3 is less active
than compound 2. The binding modes of all three com-
pounds (1–3) are shown in Figure 4. All three com-
pounds are additionally stabilized by a number of
hydrophobic interactions offered by Met39, Thr41,
Phe42, Phe44, Pro65 and Val69 at the A’ B loop of the
IL-2. Our docking results revealed the importance of
Arg38 in the vicinity of carbonyl group of ring A, which
plays a vital role in protein-ligand complex formation
and stabilization.
The hydrogen bonding pattern of compounds 1–3
were compared with that of reference ligand 4. The
Figure 4 The binding mode analysis of Compound 1 (a), 2 (b) and 3 (c). The interaction of compounds 1–3 with Arg38 is shown. Hydrogen
bonds are displayed in green dash lines and the distances are shown in red colour.
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interaction with the side chain of Glu62 while the pep-
tide carbonyl interacts with the backbone amino group
of Lys43. Compounds 1–3 pose only one hydrogen bond
donor feature i.e. hydroxyl group at C17 of ring D,
which is surface exposed and do not contribute in
protein-ligand interaction, while carbonyl group inter-
acts with Arg38 instead of Lys43. The hydrogen bonding
patterns of compounds 1–3 are compared with the
hydrogen bonding pattern of compound 4 in Figure 5.
Methods
General methods
The 1H-NMR spectra were recorded in CDCl3 on Bruker
AM-300 and AM-400 NMR spectrometers with TMS as
an internal standard using UNIX operating system at 300
and 400 MHz, respectively. The 13C-NMR spectra were
recorded in CDCl3 at 100 MHz on Bruker AM-400 NMR
spectrometer. HREI-MS were recorded on Jeol JMS 600
and HX 110 mass spectrometers with the data system DA
5000. The IR spectra were recorded on a Jasco A-302
spectrophotometer. The UV spectra were recorded on a
Hitachi U-3200 spectrophotometer. The optical rotations
were measured on JASCO DIP-360 digital polarimeter.
The melting point was determined on a Buchi 510 appar-
atus. Column chromatography (CC) was carried on silica
gel column (70–230 Mesh). Purity of the samples was
checked by TLC on pre-coated silica gel GF-254 prepara-
tive plates (20 × 20 cm, 0.25 mm thick, Merck) and were
detected under the UV lights (254 and 366 nm), whileceric sulphate was used as spraying reagent. Dianabol (1)
was purchased from Fluka Riedel-deHaën® and the purity
was 99.0% (HPLC).
Callus culture
The plant was identified by the department of Botany,
University of Karachi. The callus cultures of the plant
were derived from young leaves cultivated in 300 mL
jars, each having 25 mL of Murashige and Skoog medium
[30], supplemented with sucrose (30 g/L), 3-indole butyric
acid (IBA) (19.7 μM), and 6-benzyl aminopurine (BA)
(4.44 μM), and solidified by agar (6 g/L) and incubated at
25 ±1°C under complete darkness.
Biotransformation protocol
Cell suspension cultures were derived from static cul-
tured calli in Erlenmeyer flasks (1000 mL), each con-
taining 400 mL of the Murashige and Skoog medium,
supplemented with ingredients as mentioned above
except BA and agar. After 15 days of pre-culturing on a
gyratory platform shaker at 100 rpm and with a 16 h
photoperiod at 25 ±1°C, a solution of substrate (100 mg
in 1 mL of acetone) was added to each flask through a
0.2 μM membrane filter and the flasks were placed on a
shaker for 20 days. The time course study was carried
out by taking aliquots from culture on daily basis and
the content of transformation was analyzed by TLC. A
negative control containing only plant cell suspension
cultures and a positive control containing compound 1
in the media were also prepared in order to check
Figure 5 The comparison of hydrogen bonding pattern of compounds 1–3 with reference compound 4. Hydrogen bonding of reference
compound with Arg38 (a) and Hydrogen bonding of compound 1-3 with Arg38 (b).
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the chemical changes as a result of chemical reaction
(if any) due to media components, respectively.
Immunomodulatory studies
Reagents, chemicals, and equipments
Luminol (3-aminophthalhydrazide), Hanks Balance Salts
Solution (HBSS) and Lymphocytes Separation Medium
(LSM) were purchased from Research Organics, Sigma,
Germany, and MP Biomedicals, Inc., Germany, respec-
tively. Zymosan-A (Saccharomyces cerevisiae origin),
Dimethylsulfoxide (DMSO), ethanol and ammonium chlo-
ride of analytical grades were purchased from Merck
Chemicals, Darmstadt, Germany. The Luminometer used
was Luminoskan RS, Finland.
Isolation of human polymorphonuclear cells (PMNs)
Heparinized blood was obtained by vein puncture asep-
tically from healthy volunteers (25 – 38 years age). The
buffy coat containing PMNs was collected by dextran
sedimentation and the cells were isolated after the LSM
density gradient centrifugation from the tube base. Cellswere washed twice and suspended in Hank’s Balance Salt
Solution (Ca2+ and Mg2+ free) (HBSS–), pH 7.4. Neutro-
phils were purified from RBCs (red blood cells) contam-
ination using hypotonic solution. Cells were adjusted to
their required concentration using Hank’s Balance Salt
Solution containing Ca2+ and Mg2+ (HBSS++).
Oxidative burst study
Luminol -enhanced chemiluminescence assay was per-
formed as described by Helfand et al. [31] and Haklar
et al. [32] with some modifications. Briefly, 25 μL di-
luted whole blood (1:200 dilutions in sterile HBSS++) or
25 μL of PMNs (1 × 106) cells were incubated with
25 μL of serially diluted compounds with concentration
ranges between 3.2–50 mg/mL. Tests were performed
in white 96-well plates, which were incubated at 37°C
for 30 minutes in the thermostatic chamber of the
luminometer. Opsonised zymosan-A, 25 μL followed by
25 μL luminol (7 × 10-5 M) along with HBSS++ was added
to each well to obtain a 100 μL volume/well. Wells re-
ceived HBSS++ and cells but no compounds were used as
a negative control. Chemiluminescence peaks were
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as chemiluminescence relative light units (RLU) with peak
and total integral values.
T- Cell proliferation assay
The T-cell proliferation assay was performed as des-
cribed by Nielsen et al. [33]. In this assay, isolated
lymphocytes were stimulated by adding the phytohem-
agglutinin (PHA) in culture. The rate of proliferation
and survival was measured by radio-labelled thymidine
incorporation method. The lymphocytes were isolated as
described by Boyum [34]. A 50 μL of cell suspension
(106/mL) was added to each well of a 96-well round bot-
tom tissue culture plate. 50 μL of PHA was added in
each well from the working solution (20 μg/mL) to have
final concentration 5 μg/mL. The final volume was ad-
justed to 200 μL in each well by adding complete RPMI
media. The plates were incubated at 37˚C for 72 hours
(90% humidity, 5% CO2 /air). Methyl-
3H thymidine
(Amersham Pharmacia Biotech) 0.5 μCi was added in
each well and incubated for further 18 hours. Cells were
harvested on a filter mat (Type G-7) using cell harvester
(INOTECH IH-280, Switzerland) and the radioactivity
(CPM) was measured using a β-scintillation counter (LS
6500, Beckman Coulter, USA). The control drug pred-
nisolone was purchased from Sigma Aldrich™.
IL-2 Cytokine production
IL-2 cytokine was produced from peripheral blood
mononuclear cells (PBMC). IL-2 cytokine production by
PHA activated cells in the presence or absence of test
compounds was studied by ELISA using the human
cytokine kit (Diaclone, Besancon Cedex France). Briefly,
freshly prepared mononuclear cells (105/well) were
cultured in 96-well microtiter flat bottom plate in the
presence or absence of 5 μg/mL PHA. Four different
concentrations (10.33-331.13 μM/mL) of compounds,
along with PHA, were used in this assay. The culture
plate was incubated at 37°C for 18 h. Then the super-
natant was collected and analyzed for IL-2 cytokine pro-
duction following kit manufacturer instructions. Results
of all above test are presented in Table 1.
Statistical analysis
Students T-test was performed to compare the significance
mean differences between the control and tested extracts
for various chemiluminescence results. The differences
were considered to be significant at levels of P ≤ 0.05.
Anticancer activity
The sulforhodamine B (SRB) protein staining assay was
employed for measurement of in vitro growth inhibition
and cytotoxicity [35]. The appropriate cell density (cells/
well) of NCI-H460 cells (1 × 104) was added in 96-wellplates. The cell density used was dependent on the
doubling time of the cell line leading to the formation of
monolayer. After 24 h incubation, different doses of
compounds 1–3 were added and incubated for further
48 h. This was followed by fixation of cells with ice-cold
trichloroacetic acid (50 μl, 50%) at room temperature for
30 min. The plates were carefully washed five times with
distilled water, and left for overnight drying in air.
Sulforhodamine B dye (100 μl, 0.4% in 1% acetic acid)
was introduced in each well and after 30 min residual
dye was removed using acetic acid (1%) and air-dried
overnight. The bound SRB dye was solubilised in Tris-
base solution (100 μl, 10 mM) with gentle shaking on a
plate-shaker for 5 min prior to optical density (OD)
measurements at 545 nm in a plate reader. From the op-
tical densities values, the percentage growths inhibition
was calculated using the following formulae:
If T≥Tz;
the Percentage growth of cells
¼ 100 T Tzð Þ= C Tzð Þ½ 
If T < Tz;
the Percentage growth of cells
¼ 100 T Tzð Þ=Tz½ 
where T and Tz indicates the absorbance values at the
time cells received the tested compound (Tz) and after a
period of treatment (T), C indicates the absorbance
value measured in untreated cells (control) after an incu-
bation period equal to the treatment period.
Percent growth inhibition ¼ 100%
percentage growth of cells
From the percentage growth, a dose response curve
was generated between the sample concentration and
percent growth of the cells to determine GI50 and
TGI LC50 parameters.
Where GI50 parameter indicates the sample concentra-
tion for growth inhibition (50%) of total cells. TGI indi-
cates the sample concentration for complete growth
inhibition (100%) of the cells.
Molecular docking protocol
The three dimensional structure of Human IL-2 in complex
with compound 4 [2-[2-(1-Carbamimidoyl-Piperdin-3-yl)-
acetylamino]-3-{4-[2-(3-Oxalyl-1H-Indol-7-yl) ethyl] phe -
nyl}-propionic acid methyl ester] was downloaded from
protein data bank [PDB ID: 1 M49; resolution 2.0 Å].
Docking protocol was evaluated through re-docking
process in which the co-crystallized compound was extra-
cted and re-docked into the binding cavity, and the quality








1 −6.7 ——— ———— ————
2 −10.8 2.8 (NH2ε) and
2.2 (NH2ŋ2)
———— ————
3 −9.8 2.9 Å (NH2ε) and
3.5 Å (NH2ŋ2)
———— ————
4 −26.0 ———— 2.9 Å (NH2) 2.8 Å (O1) and
3.0 Å (O2)
Prednisolone −28.2 ——— 2.44 3.34
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http://journal.chemistrycentral.com/content/7/1/163of docking protocol was evaluated through root mean
square deviation (RMSD ≤2 Å is considered as best). In this
study, Compound 4 was used as a reference for docking
studies. Compound 4 was synthesized by Tilley et al. [36],
and its chemical characterization is reported. The com-
pound was co-crystallized with IL-2 by Arkin et al., [37].
The re-docking of compound 4, suggested that the docking
protocol is suitable for the docking analysis of comp. 1–3.
The three-dimensional structures of compounds 1–3
were generated by molecular modeling software SYBYL
6.9 [38]. Energy minimization was carried out using the
Tripos force field with a distance gradient algorithm with
a convergence criterion of 0.05 kCal/ (molÅ) and max-
imum 10,000 iterations, respectively, with Gasteiger–
Hǘckel charges (TRIPOS Inc) [39].
Docking of ligand 1–3 into the active site of IL-2 receptor
was performed using FlexX docking software implemented
in SYBYL6.9. FlexX software is a fast and flexible algorithm
for docking small ligand into binding sites of the enzymes,
using an incremental construction algorithm that actually
builds the ligand in the binding site [40]. The software in-
corporates protein–ligand interactions, placement of the
ligand core, and rebuilding of the complete ligand. A recep-
tor description file (RDF) was created from the PDB coordi-
nates. The active site for docking was defined as all atoms
within 6.5 Å radius of the co-crystallized ligand 4. The pro-
posed interaction mode of the ligand in the active-site of
IL-2 was determined as the highest scored conformation
(best fit ligand) among 30-generated conformations and
binding modes generated according to FlexX scoring func-
tion, which is the structure with the most favourable free
energy of binding. Docking results were analyzed by VMD
(visual molecular dynamics) [41]. Docking energies and
H-Bond distances with the Arg38 are presented in Table 3.
Conclusion
Biotransformational studies resulted in the production of
two metabolites, 2 and 3 (first time using this way) when
cell suspension culture of A. indica was incubated with
compound 1. Metabolite 2 exhibited potent and differentialin-vitro immunomodulatory activity particularly against T-
cell proliferation; this was further resulted into significantly
interfere with IL-2 protein. Comparably, metabolite 3 and
substrate (1) did not show considerable results. Compound
2 also demonstrated a moderate anti-cancerous activity
slightly higher than the parent compound but no activity
was observed for metabolite 3. All the compounds (1–3)
were found similar according to their binding pattern to IL-
2 protein in molecular docking studies but the binding
score was lowest for metabolite 2.
Additional file
Additional file 1: Table S1. 1H NMR (300 MHz, CDCl3)
a) chemical
shifts of compound 1 and its metabolites 2 and 3. δ in ppm and J in Hz.
Table S2. 13C NMR (100 MHz, CDCl3)
a)b) chemical shifts of compound 1
and its metabolites 2 and 3.
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